TAE and UKAEA launch fully funded TAE Beam UK to commercialise neutral beam fusion tech

TAE Beam UK team members at the UKAEA’s Culham Campus in Oxfordshire, where the joint venture will develop neutral beam particle accelerator technology for fusion energy and wider commercial applications

(Image courtesy of TAE Technologies)

TAE Technologies and the UK Atomic Energy Authority (UKAEA) confirmed on 14 May 2026 that TAE Beam UK, their joint venture targeting particle accelerator technology for fusion and other markets, is formally established in the UK and fully funded. The announcement says the milestone advances the commercialisation of neutral beams, a particle accelerator technology that heats plasma and sustains the conditions a fusion reactor needs to generate electricity. Both companies describe reliable supply of components like neutral beams as one of the key challenges for the fusion industry, and TAE Beam UK is structured to address it.

Neutral beam technology and what TAE Beam UK will build

TAE Beam UK’s technical programme opens with the development of neutral beams. UKAEA’s December 2025 press release describes the underlying physics: protons are accelerated and combined with electrons to create a stream of neutral, high-energy hydrogen atoms that can bypass a reactor’s magnetic field to deliver heating, current drive, and plasma stability. TAE reports using eight such beams on its current fusion machine, positioned at precise angles to maintain plasma confinement at fusion-relevant conditions.

TAE brings more than two decades of patented intellectual property and accelerator R&D to the venture. That expertise has produced a power plant design the company describes as smaller, more efficient, and more cost-effective than other fusion concepts. UKAEA contributes more than 40 years of fusion energy research, including decades of experience running and maintaining the neutral beam system on the Joint European Torus (JET) at Culham. UKAEA plans to make an equity investment of £5.6 million in the joint venture, while TAE describes its own contribution as a nine-figure investment in the technology, driven by its usage requirements over the coming years. The partnership is targeting delivery of first short-pulse beams within 18 to 24 months of the start of work, subject to customary regulatory approvals.

Industrial scaling beyond plasma confinement applications

TAE Beam UK is also positioned to serve fusion configurations beyond TAE’s own first power plant design, broadening its role in the global fusion supply chain. The particle accelerator technology has confirmed commercial uses outside fusion as well. Food safety, homeland security, and the BNCT-based cancer therapy under development at TAE’s biotech subsidiary TAE Life Sciences all draw on the same accelerator platform, which in this reading diversifies the venture’s addressable market beyond fusion alone.

TAE already operates its power management subsidiary, TAE Power Solutions, from the West Midlands, and TAE Beam UK extends that UK footprint further at the UKAEA’s Culham Campus in Oxfordshire. Both organisations describe the joint venture as an anchor in the world’s fusion supply chain, with high-skilled job creation as a direct outcome. The announcement frames full funding as unlocking the next phase of a commercialisation roadmap that the two organisations set out when they announced the strategic partnership in 2025.

Stay ahead in the fusion revolution explore more breakthroughs from leading innovators in clean energy technology.